Palomino Laboratories (PALX) Change in Accured Expenses (2023 - 2025)

Palomino Laboratories (PALX) has 3 years of Change in Accured Expenses data on file, last reported at $464910.0 in Q3 2025.

• For the quarter ending Q3 2025, Change in Accured Expenses rose 16486.16% year-over-year to $464910.0; the trailing twelve-month figure through Sep 2025 stood at $458934.0 (up 2413.74% YoY), and the FY2024 full-year result was $5443.0, up 143.75% from the prior year.
• Change in Accured Expenses improved to $464910.0 in Q3 2025, from -$5035.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $464910.0 in Q3 2025 to a low of -$41256.0 in Q4 2024.
• A 3-year average of $59648.9 and a median of -$177.5 in 2024 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 16486.16% in 2025, while the deepest fall reached 59.44% in 2025.
• Tracing PALX's Change in Accured Expenses over 3 years: stood at -$28442.0 in 2023, then tumbled by 45.05% to -$41256.0 in 2024, then jumped by 1226.89% to $464910.0 in 2025.
• Business Quant data shows PALX's Change in Accured Expenses at $464910.0 in Q3 2025, -$5035.0 in Q2 2025, and $40315.0 in Q1 2025.